ARTERİOVENÖZ FİSTÜL YARASI OLAN BİR OLGUDA YARA BAKIMI
Öz
Anahtar Kelimeler
Kaynakça
- V Falanga, WH Eaglstein, B Bucalo, MH Katz, B Harris, P Carson. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. Clinical Trial J Dermatol Surg Oncol. 1992 Jul;18(7):604-6.
- V Krishna Mohan, Recombinant human epidermal growth factor (REGEN-D 150): effect on healing of diabetic foot ulcers, Diabetes Res Clin Pract,. 2007 Dec;78(3):405-11.
- Hong JP, Jung HD, Kim YW. Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers. Ann Plast Surg. 2006 Apr;56(4):394-8.
- Nolan C, Cirillo-Penn, Matthew D Breite, Bernardo C Mendes. Impending Arteriovenous Fistula Bleeding With Skin Ulceration. Mayo Clin Proc. 2022 Aug;97(8):1577-1580.
- Weller CD, Buchbinder R, Johnston RV. Interventions for helping people adhere to compression treatments for venous leg ulceration. Cochrane Database of Systematic Reviews 2013, Issue 9.
- DA Simon, FP Dix, CN McCollum. Clinical Review, Management of venous leg ulcers. BMJ 2004; 328.
- I Richter, J Dvořák, T Jirásek, J Bartoš. Klin Onkol, The Possibility of Epidermal Growth Factor Receptor Inhibition in Anal Cancer]. 2015;28(4):260-4.
- J Hardwicke 1, D Schmaljohann, D Boyce, D Thomas. Epidermal growth factor therapy and wound healing--past, present and future perspectives. Review Surgeon. 2008 Jun;6(3):172-7.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Anesteziyoloji
Bölüm
Derleme
Yazarlar
Ergün Gündüz
*
Bu kişi benim
0000-0002-5344-8250
Türkiye
Yayımlanma Tarihi
15 Aralık 2022
Gönderilme Tarihi
3 Ekim 2022
Kabul Tarihi
23 Ekim 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 2 Sayı: 5